Navigation Links
How to deliver the news? New advice for doctors diagnosing prenatal Down syndrome
Date:9/27/2009

BOSTON September 28th, 2009 New prenatal tests for Down syndrome are soon to be offered to all pregnant women across the United States, yet telling an expectant couple that their child will be born with Down syndrome is a task very few physicians are trained for, claims research published in the American Journal of Medical Genetics. The study, which reviewed decades of surveys and interviews, offers several recommendations for how physicians can best deliver the news.

A 29-member research team, led by Dr. Brian Skotko from Children's Hospital Boston, supported by the National Down Syndrome Society and informed by experts from across the field, reviewed surveys and research ranging from 1960 to present day to consider how prepared physicians felt they are to deliver a diagnosis. They also studied the opinions of couples who had received the diagnosis to determine the best way of delivering the news.

"Down syndrome (DS) remains the most common chromosomal condition. It occurs in one out of every 733 live births," said Skotko. "Nearly every obstetrician can expect to have a conversation with expectant parents about the realities of life with DS, but very little research has been dedicated to understanding how physicians should communicate the news."

The team found that in a 2004 survey approximately 45% of obstetric fellows rated their training as "barely adequate or nonexistent"; a similar survey four years later found little change as 40% thought their training was "less than adequate." In 2005 a survey of 2,500 medical students showed that 81% believed they were "not getting any clinical training regarding individuals with intellectual disabilities."

To improve this scenario the team set out to answer five critical questions which every physician should consider before delivering a diagnosis: Who is the best person to communicate the news? When is the best time to share the news? Where should the news be delivere
'/>"/>

Contact: Ben Norman
Benorman@wiley.com
44-124-377-0375
Wiley-Blackwell
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. University of Iowa scientists use blood-brain barrier as therapy delivery system
2. Daily bathroom showers may deliver face full of pathogens, says CU-Boulder study
3. Encap agrees colonic drug delivery licensing deal
4. Finding the ZIP-code for gene therapy: Scientists imitate viruses to deliver therapeutic genes
5. U-Iowa improves delivery of cancer-fighting molecules
6. UCSB scientists discover potential drug delivery system
7. New cancer drug delivery system is effective and reversible
8. Nanoparticle-delivered suicide genes slowed ovarian tumor growth
9. Nanodiamonds deliver insulin for wound healing
10. Striata and CIC Launch Integrated eSignature, eDelivery, and eBilling for the Financial Services Industry
11. Preventing ear infections in the future: Delivering vaccine through the skin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... out of a nagging mystery about the development of animal ... why animal species didn,t flourish sooner, once sufficient oxygen covered ... of the Proterozoic period, about 800 million years ago — ... researchers think there also was plenty of oxygen? , Well, ... , In a study published Oct. 30 in Science ...
(Date:10/31/2014)... green space in cities is good for attracting species, but ... environments, a University of Iowa study has found. , The ... in Iowa, and recorded the abundance of two insects that ... of the trees, black cherry and black walnut, they didn,t ... fruit flies that feed on the walnuts and black cherries ...
(Date:10/31/2014)... uncovered key steps involved in programmed cell death, offering ... cancers and neurodegenerative diseases. , The research teams ... to discover the three-dimensional structure of a key cell ... in how it causes cell death. Their studies were ... Proceedings of the National Academy of Sciences ...
Breaking Biology News(10 mins):Lack of oxygen delayed the rise of animals on Earth 2Green spaces don't ensure biodiversity in urban areas 2A matter of life and death: Cell death proteins key to fighting disease 2
... are developing a cost-effective electronic monitoring system that will ... ecosystems by allowing users to track water-quality data from ... a National Science Foundation (NSF) grant. "Our goal ... environmental conditions in the Chesapeake Bay, the sounds of ...
... to help the government cut through red tape and roll ... This week, the university,s Durham Energy ... meet with the Department of Energy & Climate Change to ... on Wednesday November 3rd will also be attended by Ofgem ...
... Calif., Nov. 1, 2010 General Manifolds LLC, a ... that the United States Patent and Trademark Office has ... method for simulating functions within the cerebral cortex of ... a broad range of applications from artificial intelligence to ...
Cached Biology News:Researchers developing real-time electronic monitoring for coastal waters 2Durham Energy Institute to advise government on green technology 2General Manifolds LLC Announces Issuance of US Patent in Computational Neuroscience 2
(Date:11/1/2014)... Everett Laboratories, Inc., and Quinnova Pharmaceuticals, LLC ... Exeltis in the U.S. market. This renaming consolidates their ... areas. As a result, Everett Laboratories, Inc., ... Inc., and Quinnova Pharmaceuticals, LLC, has been renamed Exeltis ... Both companies have rebranded to the Exeltis name as ...
(Date:10/31/2014)... -- Huge event with 36,000+ global professionals ... health, analysis and forecasting   CPhI Worldwide ... its most successful show to date with pre-audit figures ... this year in Paris , the ... 140+ countries representing every step of the pharmaceutical supply ...
(Date:10/31/2014)... 2014 The evening of October ... heritage in successful medical device development to give ... it takes to successfully innovate in the complex ... a two-hour on-site class, Insight gave master’s program ... McCormick School of Engineering, medical and law schools ...
(Date:10/31/2014)... Following the successful launch of On Demand Services, ... its new product and demonstrate its potential to clinical ... September, Formedix On Demand Services is the first stage ... For the first time, these market-leading tools can be ... – a revolutionary new token-based payment system – Formedix ...
Breaking Biology Technology:Everett Laboratories And Quinnova Pharmaceuticals Start To Operate As Exeltis Brand 2CPhI Worldwide 2014 Announces Biggest Ever Show and Points to Pharma Growth in Brazil, Russia and Fast Emerging Africa 2CPhI Worldwide 2014 Announces Biggest Ever Show and Points to Pharma Growth in Brazil, Russia and Fast Emerging Africa 3CPhI Worldwide 2014 Announces Biggest Ever Show and Points to Pharma Growth in Brazil, Russia and Fast Emerging Africa 4CPhI Worldwide 2014 Announces Biggest Ever Show and Points to Pharma Growth in Brazil, Russia and Fast Emerging Africa 5CPhI Worldwide 2014 Announces Biggest Ever Show and Points to Pharma Growth in Brazil, Russia and Fast Emerging Africa 6Insight Product Development Gives Northwestern University Students Foundation for Innovation Success 2Insight Product Development Gives Northwestern University Students Foundation for Innovation Success 3Formedix to Introduce "Revolutionary" Clinical Trial Automation Software with Learning Webinar 2
... DIEGO, Aug. 21 NovaRx Corporation announced ... III clinical trial of,Lucanix(R) (belagenpumatucel-L) in the ... The first patient enrolled in the study ... principal investigator at the University,of California, San ...
... Arpida Ltd.,(SWX: ARPN) today announced that the ... its Marketing Authorisation Application (MAA) for,intravenous iclaprim. ... in,the European Union for the treatment of ... is a hospital antibiotic drug candidate with,potent ...
... iron are the basis for much of mankind,s technology, ... this week,s issue of the journal Nature ... and industrial researchers from the UK, USA and Lesotho, ... small amount of another common metal, manganese, to create ...
Cached Biology Technology:NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients 2NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients 3NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients 4Arpida's iclaprim MAA Accepted for Review by EMEA 2Arpida's iclaprim MAA Accepted for Review by EMEA 3Creating unconventional metals 2
EnzChek Ultra Xylanase Assay Kit *500 assays*...
Anti-DAP-1, Rabbit Monoclonal Immunogen: KLH-conjugated synthetic peptide corresponding to the C-terminal region of human DAP-1. Molecular Weight: 11 kDa Quality Assurance: Routinely eval...
Wnt-1 (G-19)...
Human Osteocalcin (1-22) mature form. Also reacts with Osteocalcin (1-44) and Osteocalcin (1-49). No reactivity with Bone sialoprotein....
Biology Products: